Moreover, the significant infiltration of CD8+ T cells and increased release of IFN-γ and granzyme B in liver and spleen provide evidence of enhanced anti-tumor activity by CD8+ T cells, compared to control group (Figure 5A). The gene discussed is IFNG; the disease is neoplasm.